Pylarify for a year.
Ended Awarded Last action
- Contract number
- 36C25023F0268
- Awardee
-
Progenics Pharmaceuticals Inc. UEI YLYKVRPCTCR3 Part of Lantheus Holdings, Inc.
- Awarding agency
-
Veterans Integrated Service Network 10
Veterans Health Administration, Department of Veterans Affairs
- Obligated
- $886,928
Award facts
- Contract value 100% obligated
- $886,927.68 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- North Billerica, Billerica, MA 01862, USA
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | $21,252 | |
| Supplemental Agreement for work within scope | $23,670 | |
| Original award | $842,006 |
About this award
The U.S. Department of Veterans Affairs (VA) awarded a firm fixed price delivery order contract worth $886,927.68 to Progenics Pharmaceuticals Inc., a division of Lantheus Medical Imaging, Inc. The contract is for the delivery of PYLARIFY (piflufolastat F-18), a radioactive diagnostic agent used in positron emission tomography (PET) scans to detect, localize, and image prostate cancer. The contract has an ultimate completion date of January 14, 2024 and is not set aside for any specific business type.
Progenics Pharmaceuticals is a pharmaceutical company that specializes in innovative medicines and artificial intelligence solutions for the diagnosis and treatment of cancer and other diseases. The company has multiple Blanket Purchase Agreements (BPAs) with the VA and the Defense Health Agency (DHA) for the ongoing procurement of PYLARIFY and other radiopharmaceuticals, with the largest BPA valued at $5.5 million. These IDVs allow various government healthcare providers to streamline the ordering of Progenics' products.
Quick answers
Who was awarded contract 36C25023F0268?
36C25023F0268 was awarded to Progenics Pharmaceuticals Inc. by Veterans Integrated Service Network 10 (Veterans Health Administration) on January 1, 2023.
How much is contract 36C25023F0268 worth?
The government has obligated $886,928 on 36C25023F0268.
Is contract 36C25023F0268 an order under another contract?
Yes. 36C25023F0268 is a delivery order under 36F79719D0170, a federal supply schedule, on Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36C25023F0268 competed?
The extent of competition for 36C25023F0268 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award